Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STING: ULT Withdrawal in Gout
NCT06956885Phase 2Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2025
- Primary completion
- May 2029
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of allopurinol, febuxostat in gout, sponsored by Assistance publique - Hôpitaux de Paris. Planned start May 2025; status: not yet recruiting.
02
Drugs
allopurinolfebuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT06956885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06956885.